Insilico Takeda AI Drug Discovery Deal | Lucid Diligence Brief
Insilico and Takeda test whether Pharma.AI can convert discovery speed into…
Bayer Completes Perfuse Therapeutics Acquisition for PER-001 | Lucid Diligence Brief
Bayer has closed its acquisition of Perfuse Therapeutics, securing full rights…
Merck and Protillion Biosciences Collaboration Examined | Lucid Diligence Brief
Merck and Protillion partner on AI protein design. Assess milestones, platform…
Stipple Bio’s Lonza ADC Deal | Lucid Diligence Brief
Stipple Bio’s Lonza ADC license raises the execution test for STP-100 and…
Lucid Diligence Brief: Cytotheryx $60 million Series A in liver cell therapy
Lucid Diligence Brief: Cytotheryx $60 million Series A in liver cell therapy…
Lucid Diligence Brief: Relation and Novartis atopic disease discovery alliance
Lucid Diligence Brief: Relation and Novartis atopic disease discovery alliance…
Lucid Diligence Brief: Chiesi partners with Aliada (AbbVie) on BBB platform for LSDs
Lucid Diligence Brief: Chiesi partners with Aliada on BBB platform for LSDs…
Lucid Diligence Brief: Manifold Bio and Roche brain-shuttle collaboration
Lucid Diligence Brief: Manifold Bio and Roche brain-shuttle collaboration…